LongevityHuman RCT
Nicotinamide riboside raised NAD+ by about 60% in older adults. Nothing else clearly changed
In a six-week crossover trial of 24 healthy people aged 55 to 79, NR lifted NAD+ in blood cells and was well tolerated. Blood pressure hints were exploratory.

